NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 236 / 982

  1. Breaking bud: the effect of direct chemical modifications of phytocannabinoids on their bioavailability, physiological effects, and therapeutic potential.2023 · OpenAlex
  2. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline2023 · OpenAlex
  3. Breathing with Seagrass2023 · OpenAlex
  4. Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study2023 · Crossref
  5. Brexpiprazole versus placebo or other antidepressive agents for treating depression2023 · OpenAlex
  6. Bridging the gap: An interdisciplinary perspective on ketamine in psychiatric disorders2023 · OpenAlex
  7. Brief psychotic disorder caused by areca nut use: a case report2023 · OpenAlex
  8. British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy2023 · OpenAlex
  9. Broad group of substance use patients susceptible to developing schizophrenia2023 · Crossref
  10. Broken Intraluminal Needle in an Intravenous Drug User – A Case Report and Review2023 · Crossref
  11. Bromazolam Blood Concentrations in Postmortem Cases—A British Columbia Perspective2023 · OpenAlex
  12. Building an inpatient addiction medicine consult service in Sudbury, Canada: preliminary data and lessons learned in the era of COVID-192023 · OpenAlex
  13. Building On Success in Tobacco Control: A Roadmap Towards Tobacco-Free Oman (Perspective Review)2023 · Crossref
  14. Bundeskartellamt ermittelt gegen Coca-Cola2023 · Crossref
  15. Buprenorphine Continuation During Critical Illness Associated With Decreased Inpatient Opioid Use in Individuals Maintained on Buprenorphine for Opioid Use Disorder in a Retrospective Study2023 · Crossref
  16. Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States2023 · OpenAlex
  17. Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl2023 · OpenAlex
  18. Buprenorphine Extended-Release Treatment for Opioid Use Disorder in the Postpartum Period2023 · Crossref
  19. Buprenorphine Prescribing and Dosing Limits: Evidence and Policy Goals2023 · Crossref
  20. Buprenorphine shows lower risk of adverse neonatal outcomes than methadone2023 · Crossref
  21. Buprenorphine Utilization and Prescribing Among New Jersey Medicaid Beneficiaries After Adoption of Initiatives Designed to Improve Treatment Access2023 · OpenAlex
  22. Buprenorphine-Naloxone Film Versus Tablets for Opioid Use Disorder2023 · Crossref
  23. Buprenorphine-Naloxone Maintenance and Lactation2023 · Crossref
  24. Buprenorphine/suboxone is safe in pregnancy: substance use and stigma in the healthcare professions2023 · Crossref
  25. Bupropion does not show benefit relative to placebo for cocaine use disorder2023 · Crossref
  26. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder2023 · Crossref
  27. Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990–2019: a systematic analysis of the Global Burden of Disease Study 20192023 · OpenAlex
  28. Burden of opioid toxicity death in the fentanyl-dominant era for people who experience incarceration in Ontario, Canada, 2015–2020: a whole population retrospective cohort study2023 · OpenAlex
  29. Business Analysis of PepsiCo and Coca-Cola Companies2023 · Crossref
  30. Bystander preference for naloxone products: a field experiment2023 · Crossref
  31. C/EBPβ/AEP is age-dependently activated in Parkinson’s disease and mediates α-synuclein in the gut and brain2023 · OpenAlex
  32. Cabang – Cabang Kaligrafi Dalam Musabaqah Khattil Qur’an Dan Jenis Khat Yang Digunakan2023 · Crossref
  33. CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and mice2023 · OpenAlex
  34. Cadmium Bioconcentration and Translocation Potential in Day Neutral and Photoperiod Sensitive Hemp Grown Hydroponically for the Medicinal Market2023 · OpenAlex
  35. Cadmium exposure is associated with increased transcript abundance of multiple heavy metal associated transporter genes in roots of hemp (Cannabis sativa L.)2023 · Crossref
  36. Cadmium-free silica-encapsulated molecularly imprinted AuZnCeSeS quantum dots nanocomposite as an ultrasensitive fluorescence nanosensor for methamphetamine detection2023 · OpenAlex
  37. Caffeic Acid Markedly Induced Apoptosis of Human Multiple Myeloma Cells through the Caspase-dependent Pathway2023 · Crossref
  38. Calibration of Proximate Content of Arabica Sidikalang Green Bean Coffee Using NIRS and PLS2023 · Crossref
  39. Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature2023 · OpenAlex
  40. Can ayahuasca reduce inattention, hyperactivity and impulsivity? A pilot study2023 · Crossref
  41. Can Cellphone Usage and Internet Addiction affect the Child Development?2023 · Crossref
  42. Can counter-advertising exposing alcohol sponsorship and harms influence sport spectators’ support for alcohol policies? An experimental study2023 · Crossref
  43. Can Electroacupuncture Be Useful in Opioid-Induced Hyperalgesia? A Case Report2023 · OpenAlex
  44. Can High and Consistent School‐Related Protective Factors Prevent Cannabis Use Among American Indian Middle School Students?2023 · Crossref
  45. Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial2023 · Crossref
  46. Can research on entactogens contribute to a deeper understanding of human sexuality?2023 · OpenAlex
  47. Can secondary metabolites of plantain reduce N losses from urine patches?2023 · Crossref
  48. Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example2023 · Crossref
  49. Can we use ChatGPT for Mental Health and Substance Use Education? Examining Its Quality and Potential Harms2023 · Crossref
  50. Canada’s Cannabis Legalization with Strict Public Health Control2023 · Crossref
  51. Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder2023 · OpenAlex
  52. Canadian Medical Cannabis Use after Legalization2023 · Crossref
  53. Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis2023 · Crossref
  54. Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques.2023 · PubMed
  55. Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis2023 · Crossref
  56. Cancers Attributable to Modifiable Risk Factors: A Road Map for Prevention2023 · Crossref
  57. Candidate biomarkers in psychiatric disorders: state of the field2023 · OpenAlex
  58. Cannabidiol and Aloe vera Extract to Human Cells: Bioactive Molecules as a Promising Anti-Lung Cancer Drug2023 · OpenAlex
  59. Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota2023 · OpenAlex
  60. Cannabidiol and Cannabis Sativa as a potential treatment in vitro prostate cancer cells silenced with RBBp6 and PC3 xenograft2023 · Crossref
  61. Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review2023 · Crossref
  62. Cannabidiol As a Treatment for COVID-19 Symptoms? A Critical Review2023 · Crossref
  63. Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity2023 · Crossref
  64. Cannabidiol improves haloperidol-induced motor dysfunction in zebrafish: a comparative study with a dopamine activating drug2023 · Crossref
  65. Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir2023 · Crossref
  66. Cannabidiol inhibits Nav channels through two distinct binding sites2023 · OpenAlex
  67. Cannabidiol Knowledge, Perceptions, and Use Among Young Adults in 6 U.S. Metropolitan Areas2023 · Crossref
  68. Cannabidiol Marketing Strategies in the United States: An Analysis of Three Prominent Companies2023 · Crossref
  69. Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity2023 · OpenAlex
  70. Cannabidiol Protects Striatal Neurons by Attenuating Endoplasmic Reticulum Stress2023 · Crossref
  71. Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: A review2023 · OpenAlex
  72. Cannabidiol Rescues TNF-α-Inhibited Proliferation, Migration, and Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells2023 · OpenAlex
  73. Cannabidiol sensitizes TRPV2 channels to activation by 2-APB2023 · OpenAlex
  74. Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking adolescent rats. Focus on calcitonin gene‐related peptide's brain levels2023 · Crossref
  75. Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries2023 · OpenAlex
  76. Cannabidiol, a Regulator of Intracellular Calcium and Calpain2023 · Crossref
  77. Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications2023 · OpenAlex
  78. Cannabidiol-Loaded Nanostructured Lipid Carriers (NLCs) for Dermal Delivery: Enhancement of Photostability, Cell Viability, and Anti-Inflammatory Activity2023 · OpenAlex
  79. Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance2023 · OpenAlex
  80. Cannabidiol: Influence on B Cells, Peripheral Blood Mononuclear Cells, and Peripheral Blood Mononuclear Cell/Rheumatoid Arthritis Synovial Fibroblast Cocultures2023 · Crossref
  81. Cannabidiol‐associated hepatotoxicity: A systematic review and meta‐analysis2023 · OpenAlex
  82. Cannabigerol (CBG) signal enhancement in its analysis by gas chromatography coupled with tandem mass spectrometry2023 · Crossref
  83. Cannabinoid Content in Cannabis Flowers and Homemade Cannabis-Based Products Used for Therapeutic Purposes in Argentina2023 · Crossref
  84. CANNabinoid Drug Interaction Review (CANN-DIR™)2023 · Crossref
  85. Cannabinoid hyperemesis syndrome presenting with ventricular bigeminy2023 · Crossref
  86. Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells2023 · OpenAlex
  87. Cannabinoid Receptor mRNA Expression in Central and Peripheral Tissues in a Rodent Model of Peritonitis2023 · Crossref
  88. Cannabinoid-Based Ocular Therapies and Formulations2023 · OpenAlex
  89. Cannabinoids and the challenges of new synthetic derivatives2023 · OpenAlex
  90. Cannabinoids and Their Receptors in Skin Diseases2023 · OpenAlex
  91. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations2023 · Crossref
  92. Cannabinoids for Substance Use Disorder Treatment: What Does the Current Evidence Say?2023 · Crossref
  93. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy2023 · OpenAlex
  94. Cannabinoids in the Modulation of Oxidative Signaling2023 · OpenAlex
  95. Cannabinoids in Treating Parkinson's Disease Symptoms: A Systematic Review of Clinical Studies2023 · Crossref
  96. Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (‘CUPID’ study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial2023 · OpenAlex
  97. Cannabis Advertising Policies in the United States: State-Level Variation and Comparison with Canada2023 · Crossref
  98. Cannabis and Alcohol Use and Their Associations with Sleep: A Daily Diary Investigation of Single-Use and Co-Use in College Students2023 · Crossref
  99. Cannabis and amphetamine use among school-going adolescents in sub-Saharan Africa: a multi-country analysis of prevalence and associated factors2023 · Crossref
  100. Cannabis and Other Substance Misuse: Implications and Regulations2023 · OpenAlex